期刊
BLOOD
卷 119, 期 13, 页码 3038-3041出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2011-09-382317
关键词
-
类别
资金
- National Institutes of Health [HL64190, T32-HL07439]
- Howard Hughes Medical Institute
- Center for Cellular and Molecular Therapeutics at Children's Hospital of Philadelphia
In previous work we transferred a human factor IX-encoding adeno-associated viral vector (AAV) into skeletal muscle of men with severe hemophilia B. Biopsy of injected muscle up to 1 year after vector injection showed evidence of gene transfer by Southern blot and of protein expression by IHC and immunofluorescent staining. Although the procedure appeared safe, circulating F.IX levels remained subtherapeutic (< 1%). Recently, we obtained muscle tissue from a subject injected 10 years earlier who died of causes unrelated to gene transfer. Using Western blot, IHC, and immunofluorescent staining, we show persistent factor IX expression in injected muscle tissue. F. IX transcripts were detected in injected skeletal muscle using RT-PCR, and isolated whole genomic DNA tested positive for the presence of the transferred AAV vector sequence. This is the longest reported transgene expression to date from a parenterally administered AAV vector, with broad implications for the future of muscle-directed gene transfer. (Blood. 2012;119(13):3038-3041)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据